Sio Gene Therapies Inc. Accrued Liabilities, Current
Sio Gene Therapies Inc. had Accrued Liabilities, Current of $1.95 million as of 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-02-14
- 2022-12-31: Accrued Liabilities, Current $1.95M.
- 2022-09-30: Accrued Liabilities, Current $2.87M.
- 2022-06-30: Accrued Liabilities, Current $6.10M.
- 2022-03-31: Accrued Liabilities, Current $8.23M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2022-12-31 | $1.95M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $2.87M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.10M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $8.23M 10-Q · filed 2023-02-14 |
| 2021-12-31 | $7.76M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $7.37M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $6.39M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $9.20M 10-K · filed 2022-06-14 |
| 2020-12-31 | $7.72M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $7.84M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $8.95M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $11.32M 10-K · filed 2021-06-09 |
| 2019-12-31 | $20.33M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $21.43M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $27.70M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $20.62M 10-K · filed 2020-06-10 |
| 2018-12-31 | $22.91M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $24.32M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $25.13M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $31.86M 10-K · filed 2019-06-11 |
| 2017-12-31 | $34.94M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $33.79M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $38.04M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $34.80M 10-K · filed 2018-06-11 |
| 2016-12-31 | $25.40M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $16.43M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $11.87M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $8.32M 10-K · filed 2017-06-13 |
| 2015-12-31 | $5.40M 10-Q · filed 2016-02-09 |
| 2015-03-31 | $1.16M 10-K · filed 2016-06-06 |